James Hippel Power - 05 May 2026 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Reporting relationship: CFO
Issuer ticker: TECH
Reported as of: 05 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 07 May 2026, 17:26:24 UTC
Prior SEC filing: 24 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Andrew Nick as Attorney-in-Fact for James Hippel pursuant to Power of Attorney previously filed

Key filing fact

James Hippel Power filed Form 4 for BIO-TECHNE Corp (TECH) on 07 May 2026.

Key facts

This page summarizes James Hippel Power's Form 4 filing for BIO-TECHNE Corp (TECH).
3 reported transactions and 14 derivative rows are listed below.
Accepted by SEC: 07 May 2026, 17:26.

Change

Previous filing in this sequence was filed on 24 Apr 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001603594 Primary reporting owner

Hippel James

Relationship: CFO
Address: 614 MCKINLEY PLACE NE, MINNEAPOLIS
Signature: /s/ Andrew Nick as Attorney-in-Fact for James Hippel pursuant to Power of Attorney previously filed
Signature date: 07 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TECH transaction

Common Stock

Options Exercise

Transaction value
Shares: +62,000
Change %: +42%
Price: $47.60^*
Shares after: 210,625
Date: 05 May 2026
Ownership: Direct

TECH transaction

Common Stock

Tax liability

Transaction value
Shares: -56,955
Change %: -27%
Price: $56.68^*
Shares after: 153,670
Date: 05 May 2026
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TECH transaction Derivative

Stock Options (Right to Buy)

Options Exercise

Transaction value
Shares: -62,000
Change %: -50%
Price: $0.000000^*
Shares after: 62,068
Date: 05 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 62,000
Exercise price: $47.60
Footnotes: F1

TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 167,328
Date: 05 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 167,328
Exercise price: $66.97
Footnotes: F1

TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 40,536
Date: 05 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 40,536
Exercise price: $120.46
Footnotes: F1

TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 45,220
Date: 05 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 45,220
Exercise price: $94.52
Footnotes: F3

TECH holding Derivative

Performance Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 13,865
Date: 05 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 13,865
Exercise price
Footnotes: F2, F4

TECH holding Derivative

Performance Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 37,314
Date: 05 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 37,314
Exercise price: $84.61
Footnotes: F4

TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 45,923
Date: 05 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 45,923
Exercise price: $84.61
Footnotes: F5

TECH holding Derivative

Performance Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 24,062
Date: 05 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 24,062
Exercise price
Footnotes: F2, F6

TECH holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 8,021
Date: 05 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,010
Exercise price
Footnotes: F2, F7

TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 32,417
Date: 05 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 32,417
Exercise price: $74.91
Footnotes: F8

TECH holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 23,089
Date: 05 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 23,089
Exercise price
Footnotes: F2, F9

TECH holding Derivative

Performance Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 29,420
Date: 05 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 29,420
Exercise price
Footnotes: F2, F10

TECH holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 14,710
Date: 05 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 14,710
Exercise price
Footnotes: F2, F11

TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 37,632
Date: 05 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 37,632
Exercise price: $53.60
Footnotes: F12

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 12 footnotes

Footnote F1

Fully exercisable.

Footnote F2

Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock.

Footnote F3

Options to purchase 11,305 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026.

Footnote F4

Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Footnote F5

Options to purchase 11,481 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027, and options to purchase 11,480 shares vest on 8/15/2026.

Footnote F6

Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Footnote F7

4,010 restricted stock units vest on 8/15/2026; and 4,011 restricted stock units vest on 8/15/2027.

Footnote F8

Options to purchase 8,104 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 8,105 shares vest on 8/15/2028.

Footnote F9

11,545 restricted stock units vest on 11/1/2026; and 11,544 restricted stock units vest on 11/1/2027.

Footnote F10

Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Footnote F11

4,903 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 4,904 restricted stock units vest on 8/15/2028.

Footnote F12

Options to purchase 12,544 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .